Safety of BNT162b2 mRNA COVID-19 vaccine in patients with mast cell disorders

J Allergy Clin Immunol Pract. 2021 Sep;9(9):3487-3489. doi: 10.1016/j.jaip.2021.06.032. Epub 2021 Jul 2.
No abstract available

MeSH terms

  • BNT162 Vaccine
  • COVID-19 Vaccines*
  • COVID-19*
  • Humans
  • Mast Cells
  • RNA, Messenger
  • SARS-CoV-2

Substances

  • COVID-19 Vaccines
  • RNA, Messenger
  • BNT162 Vaccine